Skip to main content

Neuroimmunology of Paraproteinemic Neuropathies

  • Reference work entry
Handbook of Neurochemistry and Molecular Neurobiology
  • 798 Accesses

1 Introduction

Paraproteinemic neuropathies are a diverse group of disorders closely connected with the presence of an excessive amount of monoclonal antibody termed a paraprotein or M-protein or monoclonal gammopathy. Paraproteins are produced by the uncontrolled clonal proliferation of plasma cells. A paraprotein or M-protein can be associated with several malignant disorders including multiple myeloma, Waldenstrom's macroglobulinemia, and other lymphoproliferative disorders. When no underlying disease is detected, the term monoclonal gammopathy of unknown significance (MGUS) is used. MGUS is the most common of the paraproteinemias. The prevalence of MGUS in the general population increases with age and is seen in about 1% of patients older than 50 years of age and reaches approximately 3% in those older than 70 years. The incidence of MGUS seems to be higher in African-American populations. MGUS is found in approximately 5% of all patients with polyneuropathy and 10% of patients...

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 249.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Abbreviations

ELISA:

enzyme-linked immunosorbent assay

IVIg:

intravenous immunoglobulin

MGUS:

monoclonal gammopathy of unknown significance

MAG:

myelin-associated glycoprotein

PMP-22:

peripheral nerve myelin protein-22

SGGLs:

sulfated glucuronyl glycosphingolipids

SGPG:

sulfoglucuronyl paragloboside

SGLPG:

sulfoglucuronyl lactosaminyl paragloboside

TLC:

thin-layer chromatogram

WM:

Waldenstrom's macroglobulinemia

References

  • Agnello V, Chung RT, Kaplan LM. 1992. A role for hepatitis C virus infection in type II cryoglobulinemia. N Engl J Med 327: 1490–1495.

    CAS  PubMed  Google Scholar 

  • Ariga T, Kohriyama T, Freddo L, Latov N, Saito M, et al. 1987. Characterization of sulfated glucuronic acid containing glycolipids reacting with IgM M-proteins in patients with neuropathy. J Biol Chem 262: 848–853.

    CAS  PubMed  Google Scholar 

  • Ayadi H, Mihaesco, E, Congy N, Roy JP, Gendron MC, et al. 1992. H chain V region sequences of three human monoclonal IgM with anti-myelin-associated glycoprotein activity. J Immunol 148: 2812–2816.

    CAS  PubMed  Google Scholar 

  • Bataille R, Harousseau JL. 1997. Multiple myeloma. N Engl J Med 336(23): 1657–1664.

    CAS  PubMed  Google Scholar 

  • Bollensen E, Schipper HI, Steck AJ. 1989. Motor neuropathy with activity of monoclonal IgM antibody to GD1a ganglioside. J Neurol 236: 353–355.

    CAS  PubMed  Google Scholar 

  • Bollensen E, Steck AJ, Schachner M. 1988. Reactivity with the peripheral myelin glycoprotein P0 in serum from patients with monoclonal IgM gammopathy and polyneuropathy. Neurology 38: 1266–1270.

    CAS  PubMed  Google Scholar 

  • Braun PE, Frail DE, Latov N. 1982. Myelin-associated glycoprotein is the antigen for a monoclonal IgM in polyneuropathy. J Neurochem 39: 1261–1265.

    CAS  PubMed  Google Scholar 

  • Brouet JC, Mariette X, Gendron MC, Dubreuil ML. 1994. Monoclonal IgM from patients with peripheral demyelinating neuropathies crossreact with bacterial polypeptides. Clin Exp Immunol 96: 466–469.

    CAS  PubMed  Google Scholar 

  • Carpo M, Nobile-Orazi E, Meucci N, Gamba M, Barbieri S, et al. 1996. Anti-GD1a antibodies in peripheral motor syndromes. Ann Neurol 39: 539–543.

    CAS  PubMed  Google Scholar 

  • Chassande B, Leger JM, Younes-Chennoufi AB, Bengoufa D, Maisonobe T, et al. 1998. Peripheral neuropathy associated with IgM monoclonal gammopathy: Correlations between M-protein antibody activity and clinical/electrophysiological features in 40 cases. Muscle Nerve 21: 55–62.

    CAS  PubMed  Google Scholar 

  • Chou DK, Ilyas AA, Evans JE, Costello C, Quarles RH, et al. 1986. Structure of sulfated glucuronyl glycolipids in the nervous system reacting with HNK-1 antibody and some IgM paraproteins in neuropathy. J Biol Chem 261: 11717–11725.

    CAS  PubMed  Google Scholar 

  • Cohen HJ, Crawford J, Rao MK, Pieper CF, Currie MS. 1998. Racial differences in the prevalence of monoclonal gammopathy in a community-based sample of the elderly. Am J Med 104: 439–444. [Erratum, Am J Med 1998; 105: 362.]

    CAS  PubMed  Google Scholar 

  • Comi G, Roveri L, Swan A, Willison H, Bojar M, et al. 2002. A randomised controlled trial of intravenous immunoglobulin in IgM paraprotein associated demyelinating neuropathy. J Neurol 249: 1370–1377.

    CAS  PubMed  Google Scholar 

  • Connolly AM, Pestronk A, Mehta S, Yee WC, Green BJ, et al. 1997. Serum IgM monoclonal autoantibody binding to the 301 to 314 amino acid epitope of beta-tubulin: Clinical association with slowly progressive demyelinating polyneuropathy. Neurology 48: 243–248.

    CAS  PubMed  Google Scholar 

  • Dalakas MC, Quarles RH. 1996. Autoimmune ataxic neuropathies (sensory ganglionopathies): Are glycolipids the responsible autoantigens? [editorial]. Ann Neurol 39: 419–422.

    CAS  PubMed  Google Scholar 

  • Dalakas MC, Flaum MA, Rick M, Engel WK, Gralnick HR. 1983. Treatment of polyneuropathy in Waldenström's macroglobulinemia: Role of paraproteinemia and immunologic studies. Neurology 33: 1406–1410.

    CAS  PubMed  Google Scholar 

  • Dalakas MC, Quarles RH, Farrer RG, Damrosia J, Soueidan S, et al. 1996. A controlled study of intravenous immunoglobulin in demyelinating neuropathy with IgM gammopathy. Ann Neurol 40: 792–795.

    CAS  PubMed  Google Scholar 

  • Dasgupta S, Li D, Yu RK. 2004. Lack of apparent neurological abnormalities in rabbits sensitized by gangliosides. Neurochem Res 29(11): 2147–2152.

    CAS  PubMed  Google Scholar 

  • Daune GC, Farrer RG, Dalakas MC, Quarles RH. 1992. Sensory neuropathy associated with monoclonal immunoglobulin M to GD1b ganglioside. Ann Neurol 31: 683–685.

    CAS  PubMed  Google Scholar 

  • Dellagi K, Brouet JC, Perreau J, Paulin D. 1982. Human monoclonal IgM with autoantibody reactivity against intermediate filaments. Proc Natl Acad Sci 79: 446–450.

    CAS  PubMed  Google Scholar 

  • Dimopoulos MA, Alexanian R. 1994. Waldenström's macroglobulinemia. Blood 83: 1452–1459.

    CAS  PubMed  Google Scholar 

  • Dimopoulos MA, Panayiotidis P, Moulopoulos LA, Sfikakis P, Dalakas M. 2000. Waldenstrom's macroglobulinemia; clinical features, complications, and management. J Clin Oncol 18: 214–226.

    CAS  PubMed  Google Scholar 

  • Di Troia A, Carpo M, Meucci N, Pellegrino C, Allaria S, et al. 1999. Clinical features and anti-neuronal activity in neuropathy associated with IgG monoclonal gammopathy of undetermined significance. J Neurol Sci 164: 64–71.

    CAS  PubMed  Google Scholar 

  • Dispenzieri A, Kyle RA, Lacy MQ, Rajkumar SV, Therneau TM, et al. 2003. POEMS syndrome: Definitions and long-term outcome. Blood 101: 2496–2506.

    CAS  PubMed  Google Scholar 

  • Dyck PJ, Low PA, Windebank AJ, Jaradeh SS, Gosselin S, et al. 1991. Plasma exchange in polyneuropathy associated with monoclonal gammopathy of undetermined significance. N Engl J Med 325: 1482–1486.

    CAS  PubMed  Google Scholar 

  • Ellie E, Vital A, Steck A, Boiron JM, Vital C, et al. 1996. Neuropathy associated with “benign” anti-myelin-associated glycoprotein IgM gammopathy: Clinical, immunological, neurophysiological pathological findings and response to treatment in 33 cases. J Neurol 243: 34–43.

    CAS  PubMed  Google Scholar 

  • Erb S, Ferracin F, Fur P, Rosler KM, Hess CW, et al. 2000. Polyneuropathy attributes: A comparison between patients with anti-MAG and anti-sulfatide antibodies. J Neurol 247: 767–772.

    CAS  PubMed  Google Scholar 

  • Eurelings M, Notermans NC, de Donk NWCJ, Van Lokhorst HM. 2001. Risk factors for hematological malignancy in polyneuropathy associated with monoclonal gammopathy. Muscle Nerve 24: 1295–1302.

    CAS  PubMed  Google Scholar 

  • Eurelings M, Notermans NC, Lokhorst HM, Kessel B, van Jacobs BC, et al. 2006. Immunoglobulin gene analysis in polyneuropathy associated with IgM monoclonal gammopathy. J Neuroimmunol 175: 152–159.

    CAS  PubMed  Google Scholar 

  • Ferrari S, Morbin M, Nobile-Orazio E, Musso A, Tomelleri G, et al. 1998. Antisulfatide polyneuropathy: Antibody-mediated complement attack on peripheral myelin Acta Neuropathol 96: 569–574.

    CAS  PubMed  Google Scholar 

  • Freddo L, Yu RK, Latov N, Donofrio PD, Hays AP, et al. 1986. Gangliosides GM1 and GD1b are antigens for IgM M-protein in a patient with motor neuron disease. Neurology 36: 454–458.

    CAS  PubMed  Google Scholar 

  • Gemignani F, Brindani F, Alfiesi S, Giuberti T, Allegri I, et al. 2005. Clinical spectrum of cryoglobulinaemic neuropathy. J Neurol Neurosurg Psychiatry 76: 1410–1414.

    CAS  PubMed  Google Scholar 

  • Gemignani F, Pevesi G, Fiocchi A, Manganelli P, Ferraccioli G, et al. 1992. Peripheral neuropathy in essential mixed cryoglobulinemia. J. Neurol Neurosurg Psychiatry 55: 116–120.

    CAS  PubMed  Google Scholar 

  • Ghobrial IM, Gertz MA, Fonseca R. 2003. Waldenstrom macroglobulinemia. Lancet Oncol 4: 679–685.

    PubMed  Google Scholar 

  • Goldfarb AR, Weimer LH, Brannagan TH. 2005. Rituximab treatment of an IgM monoclonal autonomic and sensory neuropathy. Muscle Nerve 31: 510–515.

    PubMed  Google Scholar 

  • Gorson KC, Ropper AH, Weinberg DH, Weinstein R. 2002. Efficacy of intravenous immunoglobulin in patients with IgG monoclonal gammopathy and polyneuropathy. Arch Neurol 59: 766–772.

    PubMed  Google Scholar 

  • Hakomori S. 2002. The glycosynapse. Proc Natl Acad Sci 99(1): 225–232.

    CAS  Google Scholar 

  • Hakomori S. 2003. Structure, organization, and function of glycosphingolipids in membrane. Curr Opin Hematol 10(1): 16–24.

    CAS  PubMed  Google Scholar 

  • Hammer JA, O'Shannessy DJ, De Leon M, Gould R, Zand D, et al. 1993. Immunoreactivity of PMP-22, P0, and other 19 to 28 kDa glycoproteins in peripheral nerve myelin of mammals and fish with HNK1 and related antibodies. J Neurosci Res 35: 546–558.

    CAS  PubMed  Google Scholar 

  • Hays AP, Lee SS, Latov N. 1988. Immune reactive C3d on the surface of myelin sheaths in neuropathy. J Neuroimmunol 18: 231–244.

    CAS  PubMed  Google Scholar 

  • Hays AP, Latov N, Takatsu M, Sherman WH. 1987. Experimental demyelination of nerve induced by serum of patients with neuropathy and an anti-MAG IgM M-protein. Neurology 37: 242–256.

    CAS  PubMed  Google Scholar 

  • Ilyas AA, Chen ZW, Prineas JW. 2002. Generation and characterization of antibodies to sulfated glucuronyl glycolipids in Lewis rats. J Neuroimmunol 127: 54–58.

    CAS  PubMed  Google Scholar 

  • Ilyas AA, Quarles RH, Brady RO. 1984a. The monoclonal antibody HNK-1 reacts with a peripheral nerve ganglioside. Biochem Biophys Res Commun 122: 1206–1211.

    CAS  Google Scholar 

  • Ilyas AA, Cook SD, Dalakas MC, Mithen FA. 1992. Anti-MAG IgM paraproteins from some patients with polyneuropathy associated with IgM paraproteinemia also react with sulfatide. J Neuroimmunol 37: 85–92.

    CAS  PubMed  Google Scholar 

  • Ilyas AA, Dalakas MC, Brady RO, Quarles RH. 1986. Sulfated glucuronyl glycolipids reacting with anti-myelin-associated glycoprotein monoclonal antibodies including IgM paraproteins in neuropathy: Species distribution and partial characterization of epitopes. Brain Res 385: 1–9.

    CAS  PubMed  Google Scholar 

  • Ilyas AA, Quarles, RH, Dalakas MC, Brady RO. 1985a. Polyneuropathy with monoclonal gammopathy: Glycolipids are frequently antigens for IgM paraproteins. Proc Natl Acad Sci USA 82: 6697–6700.

    CAS  Google Scholar 

  • Ilyas AA, Chou DH, Jungalwala FB, Costello C, Quarles RH. 1990. Variability in the structural requirements for binding of human monoclonal anti-MAG IgM antibodies and HNK-1 to sphingolipid antigens. J Neurochem 55: 594–601.

    CAS  PubMed  Google Scholar 

  • Ilyas AA, Quarles RH, Dalakas MC, Fishman PH, Brady RO. 1985b. Monoclonal IgM in a patient with paraproteinemic neuropathy binds to gangliosides containing disialosyl groups. Ann Neurol 18: 655–659.

    CAS  Google Scholar 

  • Ilyas AA, Willison HJ, Dalakas MC, Whitaker JN, Quarles RH. 1988a. Identification and characterization of gangliosides reacting with IgM paraproteins in three patients with neuropathy associated with biclonal gammopathy. J Neurochem 51: 851–858.

    CAS  Google Scholar 

  • Ilyas AA, Li S-C, Chou DKH, Li YT, Dalakas MC, et al. 1988b. Gangliosides GM2, IV4GalNAcGM1b, and IV4GalNAcGD1a as antigens for monoclonal IgM in neuropathy associated with gammopathy. J Biol Chem 263: 4369–4373.

    CAS  Google Scholar 

  • Ilyas AA, Quarles RH, McIntosh TD, Dobersen MJ, Dalakas MC, et al. 1984b. IgM in a human neuropathy related to paraproteinemia binds to a carbohydrate determinant in the myelin-associated glycoprotein and to a ganglioside. Proc Natl Acad Sci USA 81: 1225–1229.

    CAS  Google Scholar 

  • Irie S, Kanazawa N, Ogino M, Saito T, Funato T. 2000. No cytomegalovirus DNA in sera from patients with anti-MAG/SGPG antibody-associated neuropathy. Ann Neurol 47(2): 274–275.

    CAS  PubMed  Google Scholar 

  • Jungalwala FB. 1994. Expression and biological functions of sulfoglucuronylglycolipids (SGGLs) in the nervous system—a review. Neurochem Res 19: 945–957.

    CAS  PubMed  Google Scholar 

  • Kahn SN, Riches PG, Kohn J. 1980. Paraproteinaemia in neurological disease: Incidence, associations, and classification of monoclonal immunoglobulins. J Clin Pathol 33: 617–621.

    CAS  PubMed  Google Scholar 

  • Kahn SN, Stanton NL, Sumner AJ, Brown MJ, Spitalnik SL, et al. 1989. Analysis of feline immune response to human-myelin-associated glycoprotein. J Neurol Sci 89: 141–148.

    CAS  PubMed  Google Scholar 

  • Kaku DA, England JD, Sumner AJ. 1994. Distal accentuation of conduction slowing in polyneuropathy associated with antibodies to myelin-associated glycoprotein and sulphated glucuronyl paragloboside. Brain 117: 941–947.

    PubMed  Google Scholar 

  • Kelly JJ. 2006. Chronic peripheral neuropathy response to rituximab. Rev Neurol Dis 3(2): 78–81.

    PubMed  Google Scholar 

  • Kelly JJ, Adelman LS, Beman E, Bahn I. 1988. Polyneuropathies associated with IgM monoclonal gammopathies. Arch Neural 45: 1355–1359.

    CAS  Google Scholar 

  • Kelly JJ, Kyle RA, O'Brien PC, Dyck PJ. 1981. Prevalence of monoclonal proteins in peripheral neuropathy. Neurology 31: 1480–1483.

    PubMed  Google Scholar 

  • Kohriyama T, Ariga T, Yu RK. 1988. Preparation and characterization of antibodies against a sulfated glucuronic acid-containing glycosphingolipid. J Neurochem 51: 869–877.

    CAS  PubMed  Google Scholar 

  • Kruse J, Mailhammer R, Wernecke H, Faissner A, Sommer I, et al. 1984. Neural cell adhesion molecules and myelin-associated glycoprotein share a common carbohydrate moiety recognized by monoclonal antibodies L2 and HNK-1. Nature 311: 153–155.

    CAS  PubMed  Google Scholar 

  • Kusunoki S, Kohriyama T, Pachner AR, Latov N, Yu RK. 1987. Neuropathy and IgM paraproteinemia: differential binding of IgM M-proteins to peripheral nerve glycolipids. Neurology 37: 1795–1797.

    CAS  PubMed  Google Scholar 

  • Kusunoki S, Shimizu J, Chiba A, Ugawa Y, Hitoshi S, et al. 1996. Experimental sensory neuropathy induced by sensitization with ganglioside GD1b. Ann Neurol 39: 424–431.

    CAS  PubMed  Google Scholar 

  • Kyle RA, Rajkumar SV. 2003. Monoclonal gammopathies of undetermined significance: A review. Immunol Rev 194: 112–139.

    CAS  PubMed  Google Scholar 

  • Kyle RA, Therneau TM, Rajkumar SV, Offord JR, et al. 2002. A long-term study of prognosis in monoclonal gammopathy of undetermined significance. N Engl J Med 346: 564–569.

    PubMed  Google Scholar 

  • Landgren O, Gridley G, Turesson I, Caporaso NE, Goldin LR, et al. 2006. Risk of monoclonal gammopathy of undetermined significance (MGUS) and subsequent multiple myeloma among African American and white veterans in the United States. Blood 107: 904–906.

    CAS  PubMed  Google Scholar 

  • Latov N. 1995. Pathogenesis and therapy of neuropathies associated with monoclonal gammopathies. Ann Neurol 37: S32–S42.

    PubMed  Google Scholar 

  • Latov N, Hays AP, Donofrio PD, Liao J, Ito H, et al. 1988. Monoclonal IgM with unique specificity to gangliosides GM1 and GD1b and to lacto-N-tetraose associated with human motor neuron disease. Neurology 38(5): 763–768.

    CAS  PubMed  Google Scholar 

  • Latov N, Sherman WH, Nemni R, Galassi G, Shyong JS, et al. 1980. Plasma cell dyscrasia and peripheral neuropathy with a monoclonal antibody to peripheral nerve myelin. N Engl J Med 303: 618–621.

    CAS  PubMed  Google Scholar 

  • Ledeen RW. 1989. Biosynthesis, metabolism, and biological effects of gangliosides. In: Margolis RU, Margolis RK (eds). Neurobiology of Glycoconjugates, Chapter 2. New York: Plenum; pp. 43–83.

    Google Scholar 

  • Lee G, Ware RR, Latov N, 1994. Somatically mutated member of the human V lambda VIII gene family encodes anti-myelin-associated glycoprotein (MAG) activity. J Neuroimmunol 51: 45–52.

    CAS  PubMed  Google Scholar 

  • Lee G, Jeong Y, Wirguin I, Hays AP, Willison HJ, et al. 2004. Induction of human IgM and IgG anti-GM1 antibodies in transgenic mice in response to lipopolysaccharides from Campylobacter jejuni. J Neuroimmunol 146(2): 63–75.

    CAS  PubMed  Google Scholar 

  • Levine TD, Pestronk A. 1999. IgM antibody-related polyneuropathies: B-cell depletion chemotherapy using rituximab. Neurology 52: 1701–1704.

    CAS  PubMed  Google Scholar 

  • Li F, Pestronk A, Griffin J, Feldman EL, Cornblath D, et al. 1991. Polyneuropathy syndromes associated with serum antibodies to sulfatide and myelin-associated glycoprotein. Neurology 41: 357–362.

    PubMed  Google Scholar 

  • Lopate G, Kornberg AJ, Yue J, Choksi R, Pestronk A. 2001. Anti-myelin associated glycoprotein antibodies: Variability in patterns of IgM binding to peripheral nerve. J Neurol Sci 188(1–2): 67–72.

    CAS  PubMed  Google Scholar 

  • Lopate G, Parks BJ, Goldstein JM, Yee WC, Friesenhahn GM, et al. 1997. Polyneuropathies associated with high titre antisulphatide antibodies: Characteristics of patients with and without serum monoclonal proteins. J Neurol Neurosurg Psychiatry 62: 581–585.

    CAS  PubMed  Google Scholar 

  • Lopez PHH, Villa AM, Sica REP, Nores GA. 2002. High affinity as a disease determinant factor in anti-GM1 antibodies: Comparative characterization of experimentally induced vs. disease-associated antibodies. J Neuroimmunol 128: 69–76.

    CAS  PubMed  Google Scholar 

  • Lunn MP, Crawford TO, Hughes RAC, Griffin JW, Sheikh KA. 2002. Anti-myelin-associated glycoprotein antibodies alter neurofilament spacing. Brain 125: 904–911.

    PubMed  Google Scholar 

  • Lunn MP, Muir P, Brown LJ, Mac Mahon EM, Gregson NA, et al. 1999. Cytomegalovirus is not associated with IgM anti-myelin-associated glycoprotein/sulphate-3-glucuronyl paragloboside antibody-associated neuropathy. Ann Neurol 46(2): 267–270.

    CAS  PubMed  Google Scholar 

  • Maeda Y, Brosnan CF, Miyatani N, Yu RK. 1991a. Preliminary studies on sensitization of Lewis rats with sulfated glucuronyl paragloboside. Brain Res 541: 257–264.

    CAS  Google Scholar 

  • Maeda Y, Bigbee JW, Maeda R, Miyatani N, Kalb RG, et al. 1991b. Induction of demyelination by intraneural injection of antibodies against sulfoglucuronyl paragloboside. Exp Neurol 113: 221–225.

    CAS  Google Scholar 

  • Maloney DG, Smith B, Rose A. 2002. Rituximab: Mechanism of action and resistance. Semin Oncol 29 (Suppl 2): 2–9.

    CAS  PubMed  Google Scholar 

  • Mariette X, Chastang C, Clavelou P, Louboutin JP, Leger JM, et al. 1997. A randomised clinical trial comparing interferon-a and intravenous immunoglobulin in polyneuropathy associated with monoclonal IgM. J Neurol Neurosurg Psychiatry 63: 28–34.

    CAS  PubMed  Google Scholar 

  • McGarry RC, Helfand SL, Quarles RH, Roder JC. 1983. Recognition of myelin-associated glycoprotein by the monoclonal antibody HNK-1. Nature 306: 376–378.

    CAS  PubMed  Google Scholar 

  • Mehndiratta MM, Sen K, Tatke M, Bajaj BK. 2004. IgA monoclonal gammopathy of undetermined significance with peripheral neuropathy. J Neurol Sci 221: 99–104.

    CAS  PubMed  Google Scholar 

  • Mendell JR, Sahenk Z, Whitaker JN, Trapp BD, Yates AJ, et al. 1985. Polyneuropathy and IgM monoclonal gammopathy: Studies on the pathogenetic role of antimyelin-associated glycoprotein antibody. Ann Neurol 17: 243–254.

    CAS  PubMed  Google Scholar 

  • Miralles GD, O'Fallon JR, Talley NJ. 1992. Plasma-cell dyscrasia with polyneuropathy. The spectrum of POEMS syndrome. N Engl J Med 327: 1919–1923.

    CAS  PubMed  Google Scholar 

  • Miyatani N, Baba H, Sato S, Kanamura K, Yuasa T, et al. 1987. Antibody to sialosyllactosaminylparagloboside in a patient with IgM paraproteinemia and polyradiculoneuropathy. J Neuroimmunol 14: 189–196.

    CAS  PubMed  Google Scholar 

  • Monaco S, Ferrari S, Bonetti B, Moretto G, Kirshfink M, et al. 1995. Experimental induction of myelin changes by anti-MAG antibodies and terminal complement complex. J Neuropathol Exper Neurol 54: 96–104.

    CAS  Google Scholar 

  • Montoto S, Rozman M, Rosinol L, Nadal E, Gine E, et al. 2003. Malignant transformation in IgM monoclonal gammopathy of undetermined significance. Semin Oncol 30: 178–181.

    CAS  PubMed  Google Scholar 

  • Nardelli E, Bassi A, Mazzi G, Anzini P, Rizzuto N. 1995. Systemic passive transfer studies using IgM monoclonal antibodies to sulfatide. J Neuroimmunol 63(1): 29–37.

    CAS  PubMed  Google Scholar 

  • Nemni R, Mamoli A, Fazio R, Camerlingo M, Quattrini A, et al. 1991. Polyneuropathy associated with IgA monoclonal gammopathy: A hypothesis of its pathogenesis. Acta Neuropathol (Berl) 81(4): 371–376.

    CAS  Google Scholar 

  • Nobile-Orazio E. 2004. IgM paraproteinaemic neuropathies. Curr Opin Neurol 17: 599–605.

    CAS  PubMed  Google Scholar 

  • Nobile-Orazio E. 2005. Treatment of dysimmune neuropathies J Neurol 252: 385–395.

    CAS  PubMed  Google Scholar 

  • Nobile-Orazio E, Barbieri S, Baldini L, Marmiroli P, Carpo M, et al. 1992. Peripheral neuropathy in monoclonal gammopathy of undetermined significance: Prevalence and immunopathogenetic studies. Acta Neurol Scand 85(6): 383–390.

    CAS  PubMed  Google Scholar 

  • Nobile-Orazio E, Manfredini E, Carpo M, Meucci N, Monaco S, et al. 1994. Frequency and clinical correlates of antineural IgM antibodies in neuropathy associated with IgM monoclonal gammopathy. Ann Neurol 36: 416–424.

    CAS  PubMed  Google Scholar 

  • Ogawa-Goto K, Abe T. 1998. Gangliosides and glycosphingolipids of peripheral nervous system myelin—a minireview. Neurochem Res 23: 305–310.

    CAS  PubMed  Google Scholar 

  • Onrust SV, Lamb HM, Balfour JA. 1999. Rituximab. Drugs 58: 79–88.

    CAS  PubMed  Google Scholar 

  • O'Shannessy DJ, Willison HJ, Inuzuka T, Doberson MJ, Quarles RH. 1985. The species distribution of nervous system antigens that react with anti-myelin-associated glycoprotein antibodies. J Neuroimmunol 9: 255–268.

    PubMed  Google Scholar 

  • Pestronk A, Choksi R, Logigian E, Al-Lozi MT. 2003a. Sensory neuropathy with monoclonal IgM binding to a trisulfated heparin disaccharide. Muscle Nerve 27: 188–195.

    CAS  Google Scholar 

  • Pestronk A, Florence J, Miller T, Choksi R, Al-Lozi MT, et al. 2003b. Treatment of IgM antibody associated polyneuropathies using rituximab. J Neurol Neurosurg psychiatry 74: 485–489.

    CAS  Google Scholar 

  • Ponsford S, Willison H, Veitch J, Morris R, Thomas PK. 2000. Long-term clinical and neurophysiological follow-up of patients with peripheral neuropathy associated with benign monoclonal gammopathy. Muscle Nerve 23: 164–174.

    CAS  PubMed  Google Scholar 

  • Qin Z, Guan Y. 1997. Experimental polyneuropathy produced in guinea-pigs immunized against sulfatide. Neuroreport 8: 2867–2870.

    CAS  PubMed  Google Scholar 

  • Quarles RH. 1989. Human monoclonal antibodies associated with neuropathy. Meth Enzymol 179: 291–299.

    CAS  PubMed  Google Scholar 

  • Quarles RH. 2002. Myelin sheaths: Glycoproteins involved in their formation, maintenance and degeneration. Cell Mol Life Sci 59: 1851–1871.

    CAS  PubMed  Google Scholar 

  • Quarles RH, Weiss MD. 1999. Autoantibodies associated with peripheral neuropathy. Muscle Nerve 22: 800–822.

    CAS  PubMed  Google Scholar 

  • Quarles RH, Ilyas AA, Willison HJ. 1986. Antibodies to glycolipids in demyelinating diseases of the peripheral nervous system. Chem Phys Lipids 42: 235–248.

    CAS  PubMed  Google Scholar 

  • Quattrini A, Carbo M, Dhaliwal JL, Sadiq AS, Lugaresi A, et al. 1992. Anti-sulfatide antibodies in neurological disease: Binding to rat dorsal root ganglia neurons. J Neurol Sci 112: 152–159.

    CAS  PubMed  Google Scholar 

  • Renaud S, Fuhr P, Gregor M, Schweikert K, Lorenz D, et al. 2006. High-dose rituximab and anti-MAG neuropathy. Neurology 66(5): 742–744.

    CAS  PubMed  Google Scholar 

  • Renaud S, Gregor M, Fuhr P, Lorenz D, Deuschl G, et al. 2003. Rituximab in the treatment of polyneuropathy associated with anti-MAG antibodies. Muscle Nerve 27: 611–615.

    CAS  PubMed  Google Scholar 

  • Ritz MF, Erne B, Ferracin F, Vitale A, Vital C, et al. 1999. Anti-MAG IgM penetration myelin fibers correlates with the extent of myelin widening. Muscle Nerve 22: 1030–1037.

    CAS  PubMed  Google Scholar 

  • Ropper AH, Gorson KC. 1998. Neuropathies associated with paraproteinemia. N Engl J Med 1338: 1601–1607.

    Google Scholar 

  • Sheikh KA, Zhang G, Gong Y, Schnaar RL, Griffin JW. 2004. An antiganglioside antibody-secreting hybridoma induces neuropathy in mice. Ann Neurol 56: 228–239.

    CAS  PubMed  Google Scholar 

  • Sherman WH, Latov N, Hays AP, Takatsu M, Nemni R, et al. 1983. Monoclonal IgMk antibody precipitating with chondroitin sulphate C from patients with axonal polyneuropathy and epidermolysis. Neurology 33: 192–201.

    CAS  PubMed  Google Scholar 

  • Simmons Z, Bromberg MB, Feldman EL, Blaivas M. 1993. Polyneuropathy associated with IgA Monoclonal gammaopathy of undetermined significance. Muscle Nerve 16: 77–93.

    CAS  PubMed  Google Scholar 

  • Smith IS. 1994. The natural history of chronic demyelinating neuropathy associated with benign IgM paraproteinemia. A clinical and neurophysiological study. Brain 117: 949–957.

    PubMed  Google Scholar 

  • Snipes GJ, Suter U, Shooter EM. 1993. Human peripheral myelin protein-22 carries the L2/HNK-1 carbohydrate adhesion epitope. J Neurochem 61: 1961–1964.

    CAS  PubMed  Google Scholar 

  • Spatz LA, Williams M, Brender B, Desai R, Latov N. 1992. DNA sequence analysis and comparison of the variable heavy and light chain regions of two IgM, monoclonal, anti-myelin associated glycoprotein antibodies. J Neuroimmunol 36: 29–39.

    CAS  PubMed  Google Scholar 

  • Steck AJ, Murray N, Justafre JC, Meier C, Toyka KV, et al. 1985. Passive transfer studies in demyelinating neuropathy with IgM monoclonal antibodies to myelin-associated glycoprotein. J Neurol Neurosurg Psychiatry 48: 927–929.

    CAS  PubMed  Google Scholar 

  • Suzuki M, Suetake K, Kasama T, Ariga T, Shiina M, et al. 2001. Characterization of a phospholipid antigen reacting with serum antibody in patients with peripheral neuropathies and paraproteinemia. J Neurochem 79: 970–975.

    CAS  PubMed  Google Scholar 

  • Svennerholm L, Bostrom K, Fredman P, Jungbjer B, Lekman A, et al. 1994. Gangliosides and allied glycosphingolipids in peripheral nerve and spinal cord. Biochim Biophys Acta 1214: 115–123.

    CAS  PubMed  Google Scholar 

  • Takatsu M, Hays AP, Latov N, Abrams GM, Nemni R, et al. 1985. Immunofluorescence study of patients with neuropathy and IgM M proteins. Ann Neural 18: 173–181.

    CAS  Google Scholar 

  • Tatum AH. 1993. Experimental paraprotein neuropathy, demyelination by passive transfer of human IgM anti-myelin associated glycoprotein. Ann Neurol 33: 502–506.

    CAS  PubMed  Google Scholar 

  • Thomas FP, Adapon PH, Goldberg GP, Latov N, Hays AP. 1989. Localization of neural epitopes that bind to IgM monoclonal autoantibodies (M-proteins) from two patients with motor neuron disease. J Neuroimmunol 21: 31–39.

    CAS  PubMed  Google Scholar 

  • Thomas FP, Trojaborg W, Nagy C, Santoro M, Sadiq SA, et al. 1981. Experimental autoimmune neuropathy with anti-GM1 antibodies and immunoglobulin deposits at the nodes of Ranvier. Acta Neuropathol (Berl) 82: 378–383.

    Google Scholar 

  • Trojaborg W, Hays AP, Berg L, van den Younger DS, Latov N. 1995. Motor conduction parameters in neuropathies associated with anti-MAG antibodies and other types of demyelinating and axonal neuropathies. Muscle Nerve 18: 730–735.

    CAS  PubMed  Google Scholar 

  • Vallat JM, Desproges-Gotteron MJ, Leboutet A, Loubet N, Gualde RT. 1980. Cryoglobulinemic neuropathy: A pathological study. Ann Neural 8: 179–185.

    CAS  Google Scholar 

  • Vallat JM, Tabaraud F, Sindou P, Preux PM, Vandenberghe A, et al. 2000. Myelin widening and MGUS-IgA: An immunoelectron microscopic study. Ann Neurol 47: 808–811.

    CAS  PubMed  Google Scholar 

  • Van den Berg L, Hays AP, Nobile-Orazio E, Kinsella LJ, Manfredini E, et al. 1996. Anti-MAG and anti-SGPG antibodies in neuropathy. Muscle Nerve 19: 637–643.

    PubMed  Google Scholar 

  • Vital A. 2001. Paraproteinemic neuropathies. Brain Pathol 11: 399–407.

    CAS  PubMed  Google Scholar 

  • Vital A, Vital C, Julien J, Baquey A, Steck AJ. 1989. Polyneuropathy associated with IgM monoclonal gammopathy. Immunological and pathological study in 31 patients. Acta Neuropathol 79: 160–167.

    CAS  PubMed  Google Scholar 

  • Vital C, Deminiere C, Bourgouin B, Lagueny A, David B, et al. 1985. Waldenstrom's macroglobulinemia and peripheral neuropathy: Deposition of M-component and kappa light chain in the endoneurium. Neurology 35(4): 603–606.

    CAS  PubMed  Google Scholar 

  • Vital C, Deminiere C, Lagueny A, Bergouignan FX, Pellegrin JL, et al. 1988. Peripheral neuropathy with essential mixed cryoglobulinemia: Biopsies from 5 cases. Acta Neuropathol (Berl) 75(6): 605–610.

    CAS  Google Scholar 

  • Vital C, Vital A, Deminiere C, Julien J, Lagueny A, et al. 1997. Myelin modifications in 8 cases of peripheral neuropathy with Waldenstrom's macroglobulinemia and anti-MAG activity. Ultrastruct Pathol 21: 509–516.

    CAS  PubMed  Google Scholar 

  • Vital C, Vital A, Ferrer X, Viallard JF, Pellegrin JL, et al. 2003. Crow–Fukase (POEMS) syndrome: A study of peripheral nerve biopsy in five new cases. J Peripher Nerv Syst 8: 136–144.

    PubMed  Google Scholar 

  • Vrethem M, Cruz M, Huang W, Malm C, Holmgren H, et al. 1993. Clinical, neurophysiological and immunological evidence of polyneuropathy in patients with monoclonal gammopathies. J Neurol Sci 114: 193–199.

    CAS  PubMed  Google Scholar 

  • Weiss MD, Dalakas MC, Lauter CJ, Willison HJ, Quarles RH. 1999. Variability in the binding of anti-MAG and anti-SGPG antibodies to target antigens in demyelinating neuropathy and IgM paraproteinemia. J Neuroimmunol 95: 174–184.

    CAS  PubMed  Google Scholar 

  • Willison HJ, Yuki N. 2002. Peripheral neuropathies and anti-glycolipid antibodies. Brain 125: 2591–2625.

    PubMed  Google Scholar 

  • Willison HJ, Paterson G, Veitch J, Inglis G, Barnett SC. 1993. Peripheral neuropathy with monoclonal IgM anti-Pr2 cold agglutinins. J Neurol Neurosurg Psychiatry 56: 1178–1183.

    CAS  PubMed  Google Scholar 

  • Willison HJ, O'Leary CP, Veitch J, Blumhardt LD, Busby M, et al. 2001. The clinical and laboratory features of chronic sensory ataxic neuropathy with anti-disialosyl IgM antibodies. Brain 124: 1968–1977.

    CAS  PubMed  Google Scholar 

  • Willison HJ, Trapp BD, Bacher JD, Dalakas MC, Griffin JW, et al. 1988. Demyelination induced by intraneural injection of human anti-myelin-associated glycoprotein antibodies. Muscle Nerve 11: 1169–1176.

    CAS  PubMed  Google Scholar 

  • Wirguin I, Briani C, Suturkova-Milosevic L, Fisher T, Della-Latta P, et al. 1997. Induction of anti-GM1 ganglioside antibodies by Campylobacter jejuni lipopolysaccharides. J Neuroimmunol 78: 138–142.

    CAS  PubMed  Google Scholar 

  • Yamawaki M, Vasques A, Ben-Younas A, Yoshino H, Kanda T, et al. 1996. Sensitization of Lewis rats with sulfoglucuronyl paragloboside: Electrophysiological and immunological studies of an animal model of peripheral neuropathy. J Neurosci Res 44: 58–65.

    CAS  PubMed  Google Scholar 

  • Yee WC, Hahn AF, Hearn SA, Rupar AR. 1989. Neuropathy in IgM lambda paraproteinaemia. Immunoreactivity to neural proteins and chondroitin sulfate. Acta Neuropathol (Berl) 78: 57–64.

    CAS  Google Scholar 

  • Yeung KB, Thomas PK, King RHM, Waddy H, Will RG, et al. 1991. The clinical spectrum of peripheral neuropathies associated with benign monoclonal IgM, IgG and IgA paraproteinemia. J Neurol 238: 383–391.

    CAS  PubMed  Google Scholar 

  • Yuki N, Yamamoto T, Hirata K. 1998. Correlation between cytomegalovirus infection and IgM anti-MAG/SGPG antibody associated neuropathy. Ann Neurol 44: 408–410.

    CAS  PubMed  Google Scholar 

  • Yuki N, Yamada M, Koga M, Odaka M, Susuki K, et al. 2001. Animal model of axonal Guillain-Barré syndrome induced by sensitization with GM1 ganglioside. Ann Neurol 49: 712–720.

    CAS  PubMed  Google Scholar 

Download references

Acknowledgements

I am grateful to Dr. Yajuan Gu for her invaluable assistance with Figure 11-1 and for review of the manuscript.

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2009 Springer Science+Business Media, LLC

About this entry

Cite this entry

Ilyas, A.A. (2009). Neuroimmunology of Paraproteinemic Neuropathies. In: Lajtha, A., Banik, N., Ray, S.K. (eds) Handbook of Neurochemistry and Molecular Neurobiology. Springer, Boston, MA. https://doi.org/10.1007/978-0-387-30375-8_11

Download citation

Publish with us

Policies and ethics